23 employees
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.
2019
$81M
from 6 investors over 6 rounds
Entact Bio raised $81M on December 6, 2022
Investors: Qiming Venture Partners USA, Logos Global Management, LP, Surveyor Capital, venBio Partners, Brandon Capital Partners and Abingworth